Clofazimine Prices

Clofazimine Prices June 2023

The price of clofazimine in the Asia Pacific reached 514,498 USD/MT in June 2023.

Clofazimine Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Clofazimine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clofazimine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of clofazimine at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of clofazimine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clofazimine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clofazimine Market Analysis

The global clofazimine market size reached US$ 2.1 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 2.8 Billion, at a projected CAGR of 3.15% during 2023-2032.

• Clofazimine has shown efficacy against resistant bacteria, which is one of the major drivers of its market expansion. There has been a rise in antibiotic-resistant strains of bacteria, such as multi-drug-resistant tuberculosis (MDR-TB), and certain forms of leprosy, which has created the need for the development and deployment of drugs that can effectively combat these infections. Globally, MDR/RR-TB estimated 160,000 deaths in 2022. Also, the estimated proportion of new TB cases with MDR/RR-TB reached 3.3% in the same year. This has increased the necessity of drugs like clofazimine that are effective in treating patients with these conditions. This drug operates by binding to bacterial deoxyribonucleic acid (DNA) and inhibiting replication, leading to bacterial cell death. This mechanism is particularly effective against mycobacteria, including those resistant to first-line antibiotics.
• Clinical trials and real-world use have also demonstrated the drug’s ability to reduce bacterial loads in patients with MDR-TB, often as part of a combination therapy. Its use in leprosy treatment has a long history of success, reducing disease transmission and preventing relapse. By effectively treating resistant infections, it plays a crucial role in global health efforts to manage and control antibiotic resistance.
• Government and policy support for the use of this drug in national treatment programs is a significant factor in its widespread adoption. Many countries, like India are including this drug in their national guidelines for treating leprosy and tuberculosis. The World Health Organization (WHO) reported that leprosy was endemic in several Indian states and union territories, with an annual case detection rate of 4.56 per 10,000 population. The country reported more than 1,25,000 new patients of leprosy every year. To counter that, the Government of India (GOI) launched the National Leprosy Eradication Programme (NLEP). It aims to eliminate leprosy in each of the districts by 2030. These government-funded health programs and subsidies help lower the cost barriers for patients, making the drug more accessible.

Clofazimine News

The report covers the latest developments, updates, and trends impacting the global clofazimine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clofazimine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the clofazimine price trend.

Latest developments in the clofazimine industry:

• In April 2024, ManKind Corporation announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for MNKD-101 (Clofazimine Inhalation Suspension), enabling the initiation of a Phase 3 study for the treatment of nontuberculous mycobacterial (NTM) lung disease. Oral clofazimine has been utilized as a treatment option for patients living with NTM lung disease and the company believes that by reducing the dose and administering it directly to the lung, they can demonstrate improved dosing, tolerability and safety.
• In January 2024, the central government of India approved a new treatment regimen for leprosy in the country from April 1, 2025. The country aims to create a leprosy-free India by 2027. The Ministry of Health and Family Welfare has taken a significant step in the multi-drug therapy (MDT) treatment regimen for leprosy patients in India. The WHO has been providing MDT free of cost, which is donated via an agreement with Novartis.

Product Description

Clofazimine is a phenazine dye with antimycobacterial properties. It is utilized to treat leprosy and certain mycobacterial infections, including multi-drug-resistant tuberculosis. It binds to bacterial deoxyribonucleic acid (DNA), disrupting replication and leading to bacterial death. It is a lipophilic compound with strong anti-inflammatory attributes and is available in oral capsule form composed of clofazimine, gelatin, and other excipients. It finds application in the treatment of leprosy, multi-drug-resistant tuberculosis, Mycobacterium avium complex, Crohn's disease, Buruli ulcer, lupus, severe acne, erythrasma, and coronavirus (COVID-19).

The drug offers several benefits, such as effectiveness against resistant bacterial strains, a long half-life, reduced inflammation, a low likelihood of resistance development, minimal drug interactions, convenient oral administration, improved quality of life, cost-effectiveness, and suitability for long-term therapy. Moreover, it is lauded for its high efficacy, versatile therapeutic uses, prolonged antibacterial effect, anti-inflammatory properties, low resistance profile, and compatibility.

Regional Coverage

The report provides a detailed analysis of the clofazimine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the clofazimine price trend. 

Global Clofazimine Price

The report offers a holistic view of the global clofazimine pricing trends in the form of clofazimine price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of clofazimine but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed clofazimine demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Clofazimine Price

European clofazimine prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed clofazimine price information for a comprehensive list of countries.

North America Clofazimine Price

The analysis of clofazimine prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific clofazimine historical data within the United States and Canada can also be provided.

Middle East and Africa Clofazimine Price

The report explores the clofazimine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on clofazimine prices for countries can also be provided.

Asia Pacific Clofazimine Price

The clofazimine pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This clofazimine price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Clofazimine Price

The analysis of clofazimine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of clofazimine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting clofazimine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clofazimine price charts ensure our clients remain at the forefront of the industry.